QualityStocksNewsBreaks – Sunshine Biopharma Inc. (NASDAQ: SBFM) Closes $6 Million Public Offering
Sunshine Biopharma (NASDAQ: SBFM) announced the closing of its previously announced public offering, generating approximately $6 million in gross proceeds before fees and expenses through the sale of 12 million common units, each including common stock or pre-funded warrants and two Series C warrants. The company said net proceeds will be used for general corporate purposes and working capital, with potential additional gross proceeds of approximately $12 million if the Series C warrants are fully exercised for cash, while Aegis Capital acted as exclusive placement agent. To view the full press release, visit https://ibn.fm/00kUr About Sunshine Biopharma Inc. Sunshine Biopharma currently markets 60 generic prescription drugs in…